OLBA HEALTHCARE HOLDINGS, INC. Consolidated Financial Results for the Nine Months Ended March 31, 2022
[Japanese GAAP]
April 28, 2022
Company name: OLBA HEALTHCARE HOLDINGS, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 2689
URL:https://www.olba.co.jp/
Representative: Yohei Maeshima, President CEO
Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department Phone: +81-86-236-1115
Scheduled date of filing quarterly securities report: May 13, 2022 Scheduled date of commencing dividend payments: -
Availability of supplementary briefing material on quarterly financial results: Unavailable Schedule of quarterly financial results briefing session: Not scheduled
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Nine Months Ended March 31, 2022 (July 1, 2021 to
March 31, 2022)
(1) Consolidated Operating Results
(% indicates changes from the previous year.)
Net sales | Operating income | Ordinary income | Net income attributable to owners of parent | |
Nine months ended March 31, 2022 March 31, 2021 | Million yen %
| Million yen %
| Million yen %
| Million yen % 1,133 28.3 883 92.3 |
(Note) Comprehensive income: Nine months ended March 31, 2022: ¥1,092 million [25.2%]
Nine months ended March 31, 2021: ¥872 million [121.2%]
Basic earnings per share | Diluted earnings per share | |
Nine months ended March 31, 2022 March 31, 2021 | Yen 186.29 145.30 | Yen - - |
(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the Accounting
Standard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. In accordance with the principle-based treatment of the standards, the consolidated operating results for the fiscal year ended June 30, 2021 have been restated retroactively. The change in net sales for the nine months ended March 31, 2021 are, therefore, not presented.
(2) Consolidated Financial Position
Total assets | Net assets | Equity ratio | |
As of March 31, 2022 As of June 30, 2021 | Million yen 42,377 36,562 | Million yen 8,888 8,131 | % 21.0 22.2 |
(Reference) Equity: As of March 31, 2022: ¥8,888 million
As of June 30, 2021: ¥8,131 million
2. Dividends
Annual dividends | |||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Year-end | Total | |
Fiscal year ended June 30, 2021 Fiscal year ending June 30, 2022 | Yen - - | Yen 0.00 | Yen - - | Yen 50.00 | Yen 50.00 |
0.00 | |||||
Fiscal year ending June 30, 2022 (Forecast) | 60.00 | 60.00 |
(Note) Revision to the forecast for dividends announced most recently: Yes
3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2022 (July 1, 2021 to June 30, 2022)
(% indicates changes from the previous corresponding period.)
Net sales | Operating income | Ordinary income | Net income attributable to owners of parent | Basic earnings per share | |
Full year | Million yen % 107,500 5.3 | Million yen % 2,000 29.8 | Million yen % 2,030 31.6 | Million yen 1,460 % 47.6 | Yen 240.04 |
(Note) Revision to the financial results forecast announced most recently: Yes
(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company began applying the Accounting
Standard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020) and other standards. Those standards have been reflected in the figures of the consolidated financial results forecast above. The changes in net sales from the previous corresponding periods have been calculated by retroactively applying those standards to the figures for the fiscal year ended June 30, 2021.
Notes:
(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes in scope of consolidation): None
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)
(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: None
(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: Yes
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None
(4) Total number of issued shares (common stock)
1) Total number of issued shares at the end of the period (including treasury stock):
March 31, 2022: 6,250,000 shares
June 30, 2021: 6,250,000 shares
2) Total number of treasury stock at the end of the period:
March 31, 2022: 163,476 shares
June 30, 2021: 167,676 shares
3) Average number of shares during the period:
Nine months ended March 31, 2022: 6,085,264 shares Nine months ended March 31, 2021: 6,082,381 shares
As of March 31, 2022, 112,400 shares of the Company's stock held by the Board Benefit Trust were included in treasury stock.
* Quarterly financial results are outside the scope of the quarterly review procedures conducted by a certified public accountant or audit corporation.
* Explanation of the proper use of financial results forecast and other notes
The figures forecasted above are based on information that is available as of the date of publication of this document, and contain a wide range of uncertain factors. Actual results may differ significantly from these figures due to factors such as changes in the business environment.
2. Quarterly Consolidated Financial Statements and Principal Notes (1) Quarterly Consolidated Balance Sheets
(Thousand yen)
Assets |
Current assets
Total current assets | 29,104,992 | 35,014,673 |
Cash and deposits
Notes and accounts receivable - trade Notes and accounts receivable - trade, and contract assets
Electronically recorded monetary claims - operating
Merchandise Other
Non-current assets
Property, plant and equipment Intangible assets
As of June 30, 2021 | As of March 31, 2022 |
2,158,875 | 2,880,571 |
18,710,644 | |
- | |
23,749,020 | |
- | |
2,246,521 | 2,408,937 |
5,431,149 | 5,502,147 |
557,800 | 473,995 |
4,653,580 | 4,619,466 |
Other | 698,501 | 764,303 |
Total intangible assets
698,501
764,303
Investments and other assets 2,104,991 | 1,978,944 |
Total non-current assets 7,457,073
7,362,714
Total assets 36,562,066 | 42,377,387 |
Liabilities
Current liabilities
Notes and accounts payable - trade 16,304,571
Electronically recorded obligations - operating Short-term borrowings
Income taxes payable
Provision for bonuses for directors (and other officers)
Provision for bonuses Other
20,719,220
6,824,412 6,052,806
520,000 2,620,000
524,874 343,566
- 12,564
35,290 70,629
1,909,551
1,454,678
Total current liabilities 26,118,699 | 31,273,465 |
275,000 110,000
Non-current liabilities
Long-term borrowings
Provision for share awards for directors (and other officers)
Retirement benefit liability Long-term accounts payable - other
155,222 201,625
398,652 425,897
279,927 278,127
Other 1,203,040 | 1,199,310 |
Total non-current liabilities 2,311,843
2,214,961
Total liabilities 28,430,543 | 33,488,426 |
Net assets
Shareholders' equity
Share capital 607,750
Capital surplus 346,954 315,704
Retained earnings
7,143,982
607,750 7,967,686
Treasury shares (246,635) | (240,155) |
7,852,050134,964
Total shareholders' equity
8,650,985
Accumulated other comprehensive income |
Valuation difference on available-for-sale securities
109,014
Remeasurements of defined benefit plans 144,507 | 128,960 |
Total accumulated other comprehensive income
279,472
237,975
Non-controlling interests - | - |
Total net assets
8,131,522
8,888,960
Total liabilities and net assets | 36,562,066 | 42,377,387 |
(2) Quarterly Consolidated Statements of Income and Comprehensive Income Quarterly Consolidated Statements of Income
Nine Months Ended March 31
(Thousand yen)For the nine months ended
March 31, 2021
For the nine months ended
March 31, 2022
Net sales | 77,608,405 | 81,756,761 |
Cost of sales 68,734,287
72,425,239
Gross profit 8,874,117 | 9,331,522 |
Selling, general and administrative expenses 7,517,478Non-operating income
Operating profit 1,356,639 | 1,678,383 |
7,653,139
Interest income Dividend income Insurance claim income Commission income Electricity sale income
264 185
899 768
2,038 7,626
24,005 15,483
6,636 5,981
Subsidy income - 3,306
Share of profit of entities accounted for using - 12,519 equity method
Other
11,044 4,517
Total non-operating income 44,889 | 50,388 |
17,880 14,297
Non-operating expenses
Interest expenses
Share of loss of entities accounted for using equity method
Electricity sale expenses Other
16,621 -
4,642 4,286
3,740 6,161
Total non-operating expenses 40,561 | 27,069 |
1,360,9671,419
Extraordinary income |
Ordinary profit
Gain on sale of property, plant and equipment
1,701,702
3,834
Total extraordinary income 1,419 | 3,834 |
824 2,444
Extraordinary losses
Loss on retirement of property, plant and equipment
Loss on sale of property, plant and equipment
- 2,675
Impairment losses - | 18,770 |
Total extraordinary losses
824
23,890
Profit before income taxes 1,361,561 | 1,681,646 |
Income taxes - current 471,830
434,896
Income taxes - deferred 5,975 | 113,099 |
Total income taxes 477,805
547,996
Profit 883,756 | 1,133,650 |
-
Profit attributable to non-controlling interests
-
Profit attributable to owners of parent | 883,756 | 1,133,650 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
KAWANISHI Holdings Inc. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 07:24:06 UTC.
